Bisphenol A (BPA) acts as an endocrine disruptor in women with Polycystic Ovary Syndrome: Hormonal and metabolic evaluation
Tài liệu tham khảo
Aleem, 2013, Haematological related perturbations in polycystic ovarian syndrome: a tertiary centre experience, Glob. Res. Anal., 2, 2277
Alonso-Magdalena, 2006, The estrogenic effect of bisphenol A disrupts pancreatic Î2-cell function in vivo and induces insulin resistance, Environ. Health Perspect., 114, 106, 10.1289/ehp.8451
Ãzr, 2014, Association between red blood cell distribution width and polycystic ovary syndrome, Endocr. Res., 40, 181
Azziz, 2006, Diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature, J. Clin. Endocrinol. Metab., 91, 781, 10.1210/jc.2005-2153
Batista, 2012, Short-term treatment with bisphenol-A leads to metabolic abnormalities in adult male mice, PLoS One, 7, 10.1371/journal.pone.0033814
Brieno-Enriquez, 2011, Human meiotic progression and recombination are affected by Bisphenol A exposure during in vitro human oocyte development, Hum. Reprod., 26, 2807, 10.1093/humrep/der249
Cabaton, 2011, Perinatal exposure to environmentally relevant levels of bisphenol A decreases fertility and fecundity in CD-1 mice, Environ. Health Perspect., 119, 547, 10.1289/ehp.1002559
Caserta, 2013, The influence of endocrine disruptors in a selected population of infertile women, Gynecol. Endocrinol., 29, 444, 10.3109/09513590.2012.758702
Celik, 2013, Assessment of impaired glucose tolerance prevalence with hemoglobin A1c and oral glucose tolerance test in 252 Turkish women with polycystic ovary syndrome: a prospective, controlled study, Hum. Reprod., 28, 1062, 10.1093/humrep/det002
Diamanti-Kandarakis, 2009, Endocrine-disrupting chemicals: an Endocrine Society scientific statement, Endocr. Rev., 30, 293, 10.1210/er.2009-0002
Dogan, 2014, Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome, Int. J. Endocrinol. Metab., 12
Ehrlich, 2012, Urinary bisphenol A concentrations and implantation failure among women undergoing in vitro fertilization, Environ. Health Perspect., 120, 978, 10.1289/ehp.1104307
Fauser, 2012, Consensus on women's health aspects of polycystic ovary syndrome (PCOS), Hum. Reprod., 27, 14, 10.1093/humrep/der396
Fernandez, 2009, Neonatal exposure to bisphenol a alters reproductive parameters and gonadotropin releasing hormone signaling in female rats, Environ. Health Perspect., 117, 757, 10.1289/ehp.0800267
Fernandez, 2010, Neonatal exposure to bisphenol a and reproductive and endocrine alterations resembling the polycystic ovarian syndrome in adult rats, Environ. Health Perspect., 118, 1217, 10.1289/ehp.0901257
Futterweit, 1999, Polycystic ovary syndrome: clinical perspectives and management, Obstet. Gynecol. Surv., 54, 403, 10.1097/00006254-199906000-00024
Ganie, 2016, Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent, Fertil. Steril., 105, 194, 10.1016/j.fertnstert.2015.09.005
Hanioka, 1998, Suppression of male-specific cytochrome P450 isoforms by bisphenol A in rat liver, Arch. Toxicol., 72, 387, 10.1007/s002040050518
Harrison, 2005, Platelets and thrombosis in myeloproliferative diseases, Hematol. Am. Soc. Hematol. Educ. Prog., 409, 10.1182/asheducation-2005.1.409
Jeelani, 2017, Polycystic ovary syndrome (PCOS) and related diseases, Pmj, 2, 23
Kandaraki, 2011, Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS, J. Clin. Endocrinol. Metab., 96, E480, 10.1210/jc.2010-1658
Kebapcilar, 2009, High mean platelet volume, low-grade systemic coagulation and fibrinolytic activation are associated with androgen and insulin levels in polycystic ovary syndrome, Arch. Gynecol. Obstet., 280, 187, 10.1007/s00404-008-0884-0
Kelly, 2002, Altered vascular function in young women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 87, 742, 10.1210/jcem.87.2.8199
Lath, 2015, Insulin resistance and lipid profile in polycystic ovary syndrome, Asian J. Biomed. Pharm. Sci., 5, 30, 10.15272/ajbps.v5i47.726
Lo, 2006, Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 91, 1357, 10.1210/jc.2005-2430
March, 2010, The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria, Hum. Reprod., 25, 544, 10.1093/humrep/dep399
Markey, 2003, Mammalian development in a changing environment: exposure to endocrine disruptors reveals the developmental plasticity of steroid-hormone target organs, Evol. Dev., 5, 67, 10.1046/j.1525-142X.2003.03011.x
Masuno, 2005, Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway, Toxicol. Sci., 84, 319, 10.1093/toxsci/kfi088
Newbold, 2007, Long-term adverse effects of neonatal exposure to bisphenol A on the murine female reproductive tract, Reprod. Toxicol., 24, 253, 10.1016/j.reprotox.2007.07.006
Newbold, 2009, Prenatal exposure to bisphenol a at environmentally relevant doses adversely affects the murine female reproductive tract later in life, Environ. Health Perspect., 117, 879, 10.1289/ehp.0800045
Papalou, 2015, White blood cells levels and PCOS: direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia, Hormones, 14, 91
Phrakonkham, 2008, Dietary xenoestrogens differentially impair 3T3-L1 preadipocyte differentiation and persistently affect leptin synthesis, J. Steroid Biochem. Mol. Biol., 110, 95, 10.1016/j.jsbmb.2008.02.006
Pilo, 1981, Testosterone potentiation of ionophore and ADP induced platelet aggregation: relationship to arachidonic acid metabolism, Thromb. Haemostasis, 46, 538, 10.1055/s-0038-1653405
Ropero, 2008, Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis, Int. J. Androl., 31, 194, 10.1111/j.1365-2605.2007.00832.x
Ross, 1999, Atherosclerosis–an inflammatory disease, N. Engl. J. Med., 340, 115, 10.1056/NEJM199901143400207
Rubin, 2001, Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels, Environ. Health Perspect., 109, 675, 10.1289/ehp.01109675
Silvia, 2015, Bisphenol-A plasma levels are related to inflammatory markers, visceral obesity and insulin-resistance: a cross-sectional study on adult male population, J. Transl. Med., 13, 169, 10.1186/s12967-015-0532-y
Somm, 2009, Perinatal exposure to bisphenol a alters early adipogenesis in the rat, Environ. Health Perspect., 117, 1549, 10.1289/ehp.11342
Souter, 2013, The association of bisphenol-A urinary concentrations with antral follicle counts and other measures of ovarian reserve in women undergoing infertility treatments, Reprod. Toxicol., 42, 224, 10.1016/j.reprotox.2013.09.008
Takeuchi, 2006, Elevated serum bisphenol A levels under hyperandrogenic conditions may be caused by decreased UDP-glucuronosyltransferase activity, Endocr. J., 53, 485, 10.1507/endocrj.K06-032
Tsilchorozidou, 2004, The pathophysiology of polycystic ovary syndrome, Clin. Endocrinol., 60, 1, 10.1046/j.1365-2265.2003.01842.x
Vandenberg, 2010, Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A, Environ. Health Perspect., 118, 1055, 10.1289/ehp.0901716
Vrbikova, 2003, Cardiovascular risk factors in young Czech females with polycystic ovary syndrome, Hum. Reprod., 18, 980, 10.1093/humrep/deg218
Wada, 2007, Life style-related diseases of the digestive system: endocrine disruptors stimulate lipid accumulation in target cells related to metabolic syndrome, J. Pharmacol. Sci., 105, 133, 10.1254/jphs.FM0070034
Wang, 2012, Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance, J. Clin. Endocrinol. Metab., 97, E223, 10.1210/jc.2011-1989
Wild, 1985, Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 61, 946, 10.1210/jcem-61-5-946
Yildiz, 2002, Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state, J. Clin. Endocrinol. Metab., 87, 3871, 10.1210/jcem.87.8.8716
Zargar, 1997, Epidemiologic and etiologic aspects of primary infertility in the Kashmir region of India, Fertil. Steril., 68, 637, 10.1016/S0015-0282(97)00269-0
Zargar, 2002, Epidemiologic and etiologic aspects of hirsutism in Kashmiri women in the Indian subcontinent, Fertil. Steril., 77, 674, 10.1016/S0015-0282(01)03241-1
Zhao, 2012, The effects of bisphenol A (BPA) exposure on fat mass and serum leptin concentrations have no impact on bone mineral densities in non-obese premenopausal women, Clin. Biochem., 45, 1602, 10.1016/j.clinbiochem.2012.08.024
Zhou, 2008, Effect of Bisphenol A on steroid hormone production in rat ovarian theca-interstitial and granulosa cells, Mol. Cell. Endocrinol., 283, 12, 10.1016/j.mce.2007.10.010
